These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Positive correlation between ADAR expression and its targets suggests a complex regulation mediated by RNA editing in the human brain. Liscovitch N; Bazak L; Levanon EY; Chechik G RNA Biol; 2014; 11(11):1447-56. PubMed ID: 25692240 [TBL] [Abstract][Full Text] [Related]
5. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs. Yuting K; Ding D; Iizasa H Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076 [TBL] [Abstract][Full Text] [Related]
6. Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma. Sharpnack MF; Chen B; Aran D; Kosti I; Sharpnack DD; Carbone DP; Mallick P; Huang K EBioMedicine; 2018 Jan; 27():167-175. PubMed ID: 29273356 [TBL] [Abstract][Full Text] [Related]
7. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic. Ganem NS; Ben-Asher N; Lamm AT Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms and implications of ADAR-mediated RNA editing in cancer. Wang C; Zou J; Ma X; Wang E; Peng G Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449 [TBL] [Abstract][Full Text] [Related]